Nerve conduction study (NCS) findings play a well-validated role in diagnosing demyelinating polyneuropathies. Common features in demyelinating polyneuropathies include slowed conduction velocity, ...
Multiple sclerosis (MS) is an immune-mediated inflammatory demyelinating disease of the central nervous system (CNS) with a variety of clinical presentations and unclear pathogenesis. More than 2.8 ...
Chronic inflammatory demyelinating polyneuropathy (CIDP) is a rare, acquired neurological disorder with heterogeneous presentation. It is a peripheral nerve system immune-mediated condition which ...
Sanofi is halting the phase 3 MOBILIZE trial evaluating riliprubart for chronic inflammatory demyelinating polyneuropathy due to lack of efficacy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results